Add this topic to your myFT Digest for news straight to your inbox
Investors are better off putting their money on test makers rather than test processors
Patients in the US are waiting more than a week for results, by which time it’s probably too late
Quest Diagnostics executive says ‘no way’ capacity will expand enough to cope with flu season
Rivalry of Silicon Valley newcomers and health test providers looks set to continue
Real-world learning is at the heart of the curriculum
Indices open lower but remain up for the month
International Edition